1

2
Cassivi Stephen D: Devices, kits and methods for surgical fastening. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, Raasch Kevin W, March 11, 2010: WO/2010/028332 (195 worldwide citation)

Devices, kits and methods used to deliver provide radioactive material and a buttress element in a variety of procedures that typically involve the use of a stapler to fasten the buttress material to tissue are described herein. The radioactive material is provided to deliver radiation energy to the ...


3
Nogami Hidekatsu: Rfidタグ、rfidタグセット及びrfidシステム (JA), Rfid tag, rfid tag set and rfid system (EN). OMRON CORPORATION, Wada Shigenori, March 11, 2010: WO/2010/026939 (50 worldwide citation)

Provided is an RFID tag by which the communication distance is not shortened even when wireless communication is performed with a metal object and broadband and high gain are achieved.  An RFID tag set and an RFID system are also provided. In an RFID tag (1), an antenna section (4) is arranged on a ...


4
Bakos Gregory J: Endoscopic needle for natural orifice translumenal endoscopic surgery. ETHICON ENDO SURGERY, Johnson Philip S, March 11, 2010: WO/2010/027688 (49 worldwide citation)

A translumenal access device may comprise a catheter, an inflatable member, a hollow needle, a stylet, and a guide wire. The catheter may comprise at least one first lumen and at least one second lumen. The at least one first lumen may be configured to slidably receive the guide wire from the proxim ...


5
DEMERS JASON A: Hemodialysis systems, cassettes and methods. DEKA PRODUCTS PARTNERSHIP, Beede Melissa A, March 11, 2010: WO/2010/027435 (45 worldwide citation)

Hemodialysis dialysis systems comprising a dialysis unit and user interface unit adapted to display safety critical information related to a dialysis process are disclosed. Hemodialysis systems of the invention may include a dialysate flow path including a balancing circuit, a mixing circuit, and/or ...


6
KAMEN DEAN: Blood treatment systems and methods. DEKA PRODUCTS PARTNERSHIP, Beede Melissa A, March 11, 2010: WO/2010/027437 (39 worldwide citation)

Dialysis systems comprising actuators that cooperate to perform dialysis functions and sensors that cooperate to monitor dialysis functions are disclosed. According to one aspect, such a hemodialysis system comprises a user interface model layer, a therapy layer, below the user interface model layer ...


7
ZEITELS STEVEN M: Hydrogels for vocal cord and soft tissue augmentation and repair. The General Hospital Corporation, Baker Hunter C, March 11, 2010: WO/2010/027471 (37 worldwide citation)

The present invention provides hydrogels and compositions thereof for vocal cord repair or augmentation, as well as other soft tissue repair or augmentation (e.g., bladder neck augmentation, dermal fillers, breast implants, intervertebral disks, muscle-mass). The hydrogels or compositions thereof ar ...


8
BURGER MATTHEW T: Picolinamide derivatives as kinase inhibitors. Novartis, Voegeli Lange Regina, March 11, 2010: WO/2010/026124 (36 worldwide citation)

New picolinamide compounds, compositions and methods of inhibition of Provirus Integration of Maloney Kinase (PIM kinase) activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of ...


9
ALLEN SCOTT D: Polycarbonate polyol compositions and methods. NOVOMER, Rearick John P, March 11, 2010: WO/2010/028362 (34 worldwide citation)

In one aspect, the present disclosure encompasses polymerization systems for the copolymerization of CO2 and epoxides comprising 1) a catalyst including a metal coordination compound having a permanent ligand set and at least one ligand that is a polymerization initiator, and 2) a chain transfer age ...


10
BURGER MATTHEW: Bicyclic kinase inhibitors. Novartis, Dyer James, March 11, 2010: WO/2010/026121 (32 worldwide citation)

New compounds, compositions and methods of inhibition of Provirus Integration of Maloney Kinase (PIM kinase) activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one ...